Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

How accurate are stock forecasts?

Stock forecasts are based on technical and fundamental analysis but should not be considered as guaranteed predictions. Past performance does not guarantee future results.

How do I analyze TBPH stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate TBPH investment potential.

What is TBPH stock price today?

Get real-time TBPH stock price, historical data, and price charts on Financhill. Track TBPH performance with our advanced analysis tools.

Is TBPH a good investment?

Evaluate TBPH investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy TBPH stock?

To buy TBPH stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of TBPH?

View detailed market capitalization data and company valuation metrics for TBPH on our comprehensive analysis page.

What is the P/E ratio of TBPH?

Use our fundamental analysis tools to view TBPH P/E ratio and compare valuation metrics with industry peers.

What are TBPH earnings?

View TBPH earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

Theravance Biopharma, Inc. Stock Predictions

$0.85 Entry Open - Fortune 1000 AI Tech in Demand

DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi

Sell

TBPH
Theravance Biopharma, Inc.

Last Price:

$18.71

Seasonality Move:

7.18%

7 Day Trial

ALL ACCESS PASS

$ 7

Still Time to Get In: RAD Intel at $0.85/Share

Theravance Biopharma, Inc. Stock Forecast

Over the next 52 weeks, Theravance Biopharma, Inc. has on average historically risen by 10.4% based on the past 11 years of stock performance.
Theravance Biopharma, Inc. has risen higher in 4 of those 11 years over the subsequent 52-week period, corresponding to a historical accuracy of 36.36%
Is Theravance Biopharma, Inc. Stock Undervalued?

The current Theravance Biopharma, Inc. [TBPH] share price is $18.70. The Score for TBPH is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
TBPH is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Theravance Biopharma, Inc. Stock Go Up Next Year?

Over the next 52 weeks, Theravance Biopharma, Inc. has on average historically risen by 10.4% based on the past 11 years of stock performance.

Theravance Biopharma, Inc. Stock Rating

Sell

Theravance Biopharma, Inc. (TBPH) is a Sell

Is Theravance Biopharma, Inc. overpriced?

Theravance Biopharma, Inc. has risen higher in 4 of those 11 years over the subsequent 52-week period, corresponding to a historical accuracy of 36.36%

Theravance Biopharma, Inc. Stock Price History

Is TBPH stock going to rise?

The current trend is moderately bullish and TBPH is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:

NASDAQ

Country:

United States

Industry:

Pharmaceuticals

Sector:

Health Care

Type:

stock

Website:

theravance.com

52-Week Data

52-Week High:

20.33

52-Week Low:

7.90

Prediction Charts

Market Cap:

947.6M

Price in USD:

18.70

Volume:

331.2K

Beta:

0.72

Technical Analysis

SMA50:

15.78

SMA100:

14.28

SMA200:

12.02

52-Wk Change:

94.99%

Stock Predictions

Is Theravance Biopharma, Inc. stock public?

Yes, Theravance Biopharma, Inc. is a publicly traded company.
What is the Theravance Biopharma, Inc. stock quote today?

The Theravance Biopharma, Inc. stock price is 18.70 USD today.
How to buy Theravance Biopharma, Inc. stock online?

You can buy Theravance Biopharma, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
Nov-14	17.49	17.39	17.87	16.82
Nov-17	17.62	18.04	18.40	17.25
Nov-18	18.24	18.49	18.56	17.89
Nov-19	18.35	17.73	18.58	17.60
Nov-20	17.88	17.90	18.21	17.61
Nov-21	17.77	18.48	18.57	17.50
Nov-24	18.50	18.50	18.78	18.10
Nov-25	18.69	18.94	18.97	18.23
Nov-26	19.84	19.96	20.28	19.38
Nov-28	19.94	20.30	20.33	19.68
Dec-1	20.06	19.61	20.24	19.44
Dec-2	19.67	18.43	19.74	18.39
Dec-3	18.75	18.89	19.13	18.50
Dec-4	19.11	18.70	19.11	18.59

Theravance Biopharma, Inc. Earnings

Theravance Biopharma, Inc. Earnings Report: Per Share Theravance Biopharma, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.

Theravance Biopharma, Inc. Forecast Revenue Growth

Theravance Biopharma, Inc. Stock Analysis: Historical quarterly revenues per share for Theravance Biopharma, Inc. and historical quarterly revenue growth:

Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.31 per share, and a decrease next year of $0.18 per share.

* Theravance Biopharma, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.